Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Tacrolimus Ointment vs Protopic in Atopic Dermatitis
NCT02601703Phase 3Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Aug 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Glenmark Pharmaceuticals. Started Aug 2015; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02601703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601703.